Literature DB >> 18562980

A simple noninvasive score predicts gastroesophageal varices in patients with chronic viral hepatitis.

Ivan Gentile1, Chiara Viola, Maria Graf, Raffaele Liuzzi, Maria Quarto, Raimondo Cerini, Marcello Piazza, Guglielmo Borgia.   

Abstract

BACKGROUND: Guidelines recommend upper endoscopic screening of cirrhotic patients for gastroesophageal varices. Cirrhosis is not always distinguishable from chronic hepatitis. GOALS: To identify low-risk patients who can be spared upper endoscopy irrespective of a diagnosis of cirrhosis. STUDY: We evaluated 13 nonendoscopic variables as predictors of esophagogastric varices in 254 patients with hepatitis B or hepatitis C-related chronic liver disease who underwent upper endoscopy.
RESULTS: Any size varices occurred in 30.3% (77/254), and large varices in 12.2% of patients (31/254). Age >50 years [odds ratio (OR): 11.29; 95% confidence interval (CI): 2.33-54.67], platelet count <150,000/mmc (OR: 4.40; 95% CI: 1.85-10.45), albumin <3.6 g/dL (OR: 2.99; 95% CI: 1.31-6.79), and aspartate aminotransferase/alanine aminotransferase ratio >1 (OR: 2.83; 95% CI: 1.26-6.34) independently predicted varices by logistic regression. Using a score based on age >50 years, platelets <150,000/mmc, and aspartate aminotransferase/alanine aminotransferase ratio >1 (1 point/predictor), only 3.2% of patients with a score <2 had varices, all small.
CONCLUSIONS: Patients with chronic viral hepatitis and a score <2 need not undergo upper endoscopy, as they are unlikely to have large varices. Because about 50% of our patients had this score, 50% of upper endoscopies may be safely avoided.

Entities:  

Mesh:

Year:  2009        PMID: 18562980     DOI: 10.1097/MCG.0b013e318157464b

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  9 in total

1.  Direct-acting antivirals improve endothelial function in patients with chronic hepatitis: a prospective cohort study.

Authors:  Matteo Nicola Dario Di Minno; Pasquale Ambrosino; Antonio Riccardo Buonomo; Biagio Pinchera; Ilenia Calcaterra; Manuel Crispo; Riccardo Scotto; Francesco Borgia; Consalvo Mattia; Ivan Gentile
Journal:  Intern Emerg Med       Date:  2019-08-08       Impact factor: 3.397

Review 2.  Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.

Authors:  Agostino Colli; Juan Cristóbal Gana; Jason Yap; Thomasin Adams-Webber; Natalie Rashkovan; Simon C Ling; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2017-04-26

3.  Interferon-free regimens improve kidney function in patients with chronic hepatitis C infection.

Authors:  Nicola Coppola; Federica Portunato; Antonio Riccardo Buonomo; Laura Staiano; Riccardo Scotto; Biagio Pinchera; Stefania De Pascalis; Daniela Caterina Amoruso; Salvatore Martini; Mariantonietta Pisaturo; Carmine Coppola; Ivan Gentile
Journal:  J Nephrol       Date:  2019-04-11       Impact factor: 3.902

4.  [Splenic thickness combined with routine clinical markers predicts esophageal varices in patients with liver cirrhosis].

Authors:  Ge-Yang Dai; Zhi Liu; Fan Zeng; Dan Zhou; Lin Dai
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-10-20

Review 5.  Cirrhosis and its complications: evidence based treatment.

Authors:  Salman Nusrat; Muhammad S Khan; Javid Fazili; Mohammad F Madhoun
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

Review 6.  Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection.

Authors:  Ivan Gentile; Antonio Riccardo Buonomo; Emanuela Zappulo; Giuseppina Minei; Filomena Morisco; Francesco Borrelli; Nicola Coppola; Guglielmo Borgia
Journal:  Ther Clin Risk Manag       Date:  2014-06-26       Impact factor: 2.423

Review 7.  Current evidence on the management of hepatitis B in pregnancy.

Authors:  Alberto Enrico Maraolo; Ivan Gentile; Antonio Riccardo Buonomo; Biagio Pinchera; Guglielmo Borgia
Journal:  World J Hepatol       Date:  2018-09-27

8.  Validation of PH and Varices Risk Scores for Prediction of High-Risk Esophageal Varix and Bleeding in Patients with B-Viral Cirrhosis.

Authors:  Seunghwan Shin; Seung Up Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Beom Kyung Kim
Journal:  Diagnostics (Basel)       Date:  2022-02-09

9.  A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C.

Authors:  Ivan Gentile; Nicola Coppola; Giuseppe Pasquale; Raffaele Liuzzi; Maria D'Armiento; Maria Emma Di Lorenzo; Nicolina Capoluongo; Antonio Riccardo Buonomo; Evangelista Sagnelli; Filomena Morisco; Nicola Caporaso; Guglielmo Borgia
Journal:  Hepat Mon       Date:  2013-05-08       Impact factor: 0.660

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.